Loncar Investments, LLC is a research-focused financial index provider specializing in the biotechnology sector. Founded by investor Brad Loncar, the company's primary mission is to provide investors with exposure to transformative areas of medicine through thoughtfully constructed indexes. Their flagship products are the Loncar Cancer Immunotherapy Index (LCINDX) and the China BioPharma Index (LCHINA), which serve as the underlying basis for publicly traded ETFs (e.g., CNCR and CHNA), allowing the public to invest in a basket of companies leading these innovative fields. The firm is not a direct investment manager or broker but an intellectual property and research company that licenses its indexes to ETF providers.

Founded in

United States